FDA authorizes emergency use of convalescent plasma to treat COVID-19

The Benchmark Company’s Senior Equity Analyst, Aydin Huseynov, M.D., CFA. on emergency use of convalescent plasma to treat COVID-19
March 10, 2025
2nd Restaurant Technology Virtual Seminar
September 3, 2025
- September 4, 2025